** Carbon recycling firm LanzaTech Global's LNZA.O shares rise 5.3% to $1.58 premarket
** On Tuesday, LNZA said it is spinning out its synthetic biology platform, LanzaX, into a joint venture with Tharsis Capital to accelerate project development and financing
** The spin-out of LanzaX is expected to reduce LNZA's cost structure by ~$8 mln annually, company said
** LNZA said it's contributing its existing synbio contracts, 100+ developed molecules, and commercial expertise to LanzaX to accelerate product development
** LNZA said it is appointing a new interim chief financial officer, Justin Pugh, to focus on cost reductions and resource reallocation for its biorefining business
** LNZA fell ~71% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。